The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
Abstract
Background The intercellular adhesion molecule ICAM-1 mediates adhesion and transmigration of leucocytes to the vascular endothelial wall, a step proposed to be critical in the initiation and progression of atherosclerosis. Whether concentrations of soluble ICAM-1 (sICAM-1) are raised in apparently healthy individuals who later suffer acute myocardial infarction is unknown.Methods We obtained baseline plasma samples from a prospective cohort of 14,916 healthy men enrolled in the Physicians' Health Study. With a nested case-control design, we measured sICAM-1 concentrations for 474 participants who developed a first myocardial infarction, and 474 controls (participants who remained healthy throughout the 9-year follow-up). Cases were matched to controls according to age and smoking status at the time of myocardial infarction.Findings We found a significant association between increasing concentration of sICAM-1 and risk of future myocardial infarction (p = 0.003), especially among participants with baseline sICAM-1 concentrations in the highest quartile (> 260 ng/mL; relative risk 1.6 [95% Cl 1.1-2.4], p = 0.02). This association was present overall as well as among non-smokers, and persisted after control for lipid and non-lipid risk factors. In multivariate analyses, the risk of future myocardial infarction was 80% higher for participants with baseline sICAM-1 concentrations in the highest quartile (relative risk 1.8 [1.1-2.8], p = 0.02). Similar risk estimates were seen among non-smokers. We found slight but significant correlations between sICAM-1 and fibrinogen, high-density-lipoprotein cholesterol, homocysteine, triglycerides, tissue-type plasminogen-activator antigen, and C-relative protein, but adjustment for these altered the risk little. The risk of myocardial infarction associated with raised concentrations of sICAM-1 seemed to increase with length of follow-up.Interpretation Our data support the hypothesis that cellular mediators of inflammation have a role in atherogenesis and provide a clinical basis to consider antiadhesion therapies as a novel means of cardiovascular disease prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“sICAM-1 has been shown to be associated with increased risk of future nonfatal cardiovascular events and incident diabetes. 37,38”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [37]
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,710
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
Davies, M. J., Gordon, J. L., Gearing, A. J. H., Pigott, R., Woolf, N., Katz, D. R., & Kyriakopoulos, A. (1993) · The Journal of Pathology · doi:10.1002/path.1711710311 · Cited by 777
Pigott, R., Dillon, L. P., Hemingway, I., & Gearing, A. J. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91234-h · Cited by 650
Cited by
Sorted by citations
Items 301–400 of 999
Fielding, R. A., Atkinson, E. J., Aversa, Z., White, T. A., Heeren, A. A., Achenbach, S. J., Mielke, M. M., Cummings, S. R., Pahor, M., Leeuwenburgh, C., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00685-2 · Cited by 75
“It is not surprising that circulating levels of ICAM1 have previously been associated with cardiovascular disease onset and progression [36].”
BackgroundMarcone, S., Haughton, K., Simpson, P. J., Belton, O., & Fitzgerald, D. J. (2015) · Journal of Inflammation · doi:10.1186/s12950-014-0044-1 · Cited by 77
“The levels of these molecules also increase in association with cardiovascular risk factors, and they have been correlated with measures of atherosclerotic plaque disease and with adverse cardiovascular prognosis [45,46].”
BackgroundInflammation and Atherosclerosis
Steffens, S., & Mach, F. (2004) · Herz · doi:10.1007/s00059-004-2634-9 · Cited by 77
“Indeed, two clinical studies have demonstrated that soluble forms of P-selectin and ICAM-1 may serve as independent predictors of future cardiovascular risk [ 68 , 69].”
n-3 Fatty acids and cardiovascular disease: Actions and molecular mechanisms
Torrejón, C., Jung, U. J., & Deckelbaum, R. J. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.10.014 · Cited by 77
“Patients with manifest or future CVD have an elevated serum concentration of these inflammatory markers [55,56].”
BackgroundKuo, K., Hung, S., Lee, T., & Tarng, D. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080838 · Cited by 78
Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans
Hodgson, J., Puddey, I., Mori, T., Burke, V, Baker, R., & Beilin, L. (2001) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601231 · Cited by 76
“There is evidence that elevated plasma concentrations of endothelial cell-derived cell adhesion molecules, including E-selectin, ICAM-1 and VCAM-1, are associated with atherosclerosis and cardiovascular disease (Price & Loscalzo, 1999; Ridker et al, 1998; Rohde et al, 1998, 1999).”
Ikeda, A., Schwartz, J., Peters, J. L., Fang, S., Spiro, A., Sparrow, D., Vokonas, P., & Kubzansky, L. D. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3182312497 · Cited by 93
“8]), but no excess risks were found in other quartiles (34).”
BackgroundZhang, Q., Niu, Y., Xia, Y., Lei, X., Wang, W., Huo, J., Zhao, Q., Zhang, Y., Duan, Y., Cai, J., et al. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.135989 · Cited by 76
Relationship of Serum Inflammatory Biomarkers With Plaque Inflammation Assessed by FDG PET/CT
Duivenvoorden, R., Mani, V., Woodward, M., Kallend, D. G., Suchánková, G., Fuster, V., Rudd, J. H. F., Tawakol, A. A., Farkouh, M. E., & Fayad, Z. A. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2013.03.009 · Cited by 76
“Increased serum levels of P-selectin, E-selectin, ICAM-1, and VCAM-1 are predictive of coronary heart disease (10,11).”
BackgroundKao, A. H., Wasko, M. C., Krishnaswami, S., Wagner, J. A., Edmundowicz, D., Shaw, P., Cunningham, A. L., Danchenko, N., Sutton‐Tyrrell, K., Tracy, R. P., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.04.059 · Cited by 76
Relation of nocturnal blood pressure dipping to cellular adhesion, inflammation and hemostasis
von Känel, R., Jain, S., Mills, P. J., Nelesen, R. A., Adler, K. A., Hong, S., Perez, C. J., & Dimsdale, J. E. (2004) · Journal of Hypertension · doi:10.1097/00004872-200411000-00009 · Cited by 76
Yamamoto, H., Omelchenko, I., Shi, X., & Nuttall, A. L. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22018 · Cited by 77
“…cell interactions such as leukocyte rolling, adhesion, and transmigration in the inflamed tissues, which ultimately lead to severe energy depletion of the cells and necrotic-type cell death (Miwa et al., 1997; Ridker et al., 1998; Shi and Nuttall, 2007; Sumagin and Sarelius, 2007).”
BackgroundInfluentialHomocyst(E)Ine and Heart Disease: Pathophysiology of Extracellular Matrix
Tyagi, S. C. (1999) · Clinical and Experimental Hypertension · doi:10.3109/10641969909068660 · Cited by 76
Chen, Y., Santella, R. M., Kibriya, M. G., Wang, Q., Deyssenroth, M. A., Verret, W. J., Graziano, J. H., & Ahsan, H. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10277 · Cited by 75
“Circulating markers of systemic inflammation and endothelial dysfunction, such as soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular adhesion molecule-1 (sVCAM-1) have been shown to predict future CVD (Blankenberg et al. 2001; Hwang et al. 1997; Ridker et al. 1998, 2000).”
BackgroundMethodInfluentialPostadzhiyan, A., Tzontcheva, A., Kehayov, I. R., & Finkov, B. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.09.001 · Cited by 75
Soluble Intercellular Adhesion Molecule-1 and Risk of Future Ischemic Stroke
Tanné, D., Haim, M., Boyko, V., Goldbourt, U., Reshef, T., Matetzky, S., Adler, Y., Mekori, Y. A., & Behar, S. (2002) · Stroke · doi:10.1161/01.str.0000029007.32244.40 · Cited by 75
Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management
Salmon, J. E., & Roman, M. J. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200109000-00001 · Cited by 75
Sudden Cardiac Death, Genes, and Arrhythmogenesis
Spooner, P. M., Albert, C. M., Benjamin, E. J., Boineau, R., Elston, R. C., George, A. L., Jouven, X., Kuller, L. H., MacCluer, J. W., Marbán, E., et al. (2001) · Circulation · doi:10.1161/01.cir.103.20.2447 · Cited by 75
Stinghen, A. E. M., Gonçalves, S., Martines, E. G., Nakao, L. S., RIELLA, M. C., Aita, C. A. M., & Pecoits‐Filho, R. (2009) · Nephron Clinical Practice · doi:10.1159/000191205 · Cited by 74
Boomsma, F. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2176 · Cited by 74
PLAQUE DISRUPTION AND THROMBOSIS
Shah, P. K. (1999) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70074-6 · Cited by 74
Blake, G. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2280 · Cited by 73
Prospective Study of Effect of Androgens on Serum Inflammatory Markers in Men
Ng, M., Liu, P. Y., Williams, A. J., Nakhla, S., Ly, L. P., Handelsman, D. J., & Celermajer, D. S. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000022167.80130.a6 · Cited by 73
Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-aged men
Yusof, H. M., Miles, E. A., & Calder, P. C. (2008) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.02.002 · Cited by 74
Dietary antioxidants modulation of aging and immune-endothelial cell interaction
Meydani, M. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(99)00067-6 · Cited by 72
Soeki, T., Tamura, Y., Shinohara, H., Sakabe, K., Onose, Y., & Fukuda, N. (2003) · Circulation Journal · doi:10.1253/circj.68.1 · Cited by 72
Lipoprotein-Associated Phospholipase A2 Activity and Risk of Recurrent Stroke
Elkind, M. S. V., Tai, W., Coates, K., Paik, M. C., & Sacco, R. L. (2008) · Cerebrovascular Diseases · doi:10.1159/000172633 · Cited by 72
“Peripheral blood markers of inflammation, including leukocyte count, high-sensitivity C-reactive protein (hsCRP), and others, are associated with carotid atherosclerosis and predict incident stroke [ , , , , , , , ,”
BackgroundNylænde, M., Kroese, A., Stranden, E., Morken, B., Sandbæk, G., Lindahl, A., Arnesen, H., & Seljeflot, I. (2006) · Vascular Medicine · doi:10.1191/1358863x06vm662oa · Cited by 71
Kerr, D. M. I., Brooksbank, K. J. M., Taylor, R. G., Pinel, K., Rios, F. J. O., Touyz, R. M., & Delles, C. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001890 · Cited by 72
“It is known that proinflammatory stimuli including tobacco smoking, can stimulate the expression of adhesion molecules (ICAM-1, VCAM-1 and E-selectin) on the surface of vascular endothelial cells [27–30], suggesting that elevated levels of soluble adhesion molecules may serve as a surrogate markers to detect preclinic…”
BackgroundMeydani, M. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1665s · Cited by 75
“Interestingly, recent reports have indicated that lower concent ations of plasma sICAM-1 are associated with reduced risk of myocardial infarction (37).”
BackgroundPASSCLAIM - Diet-related cardiovascular disease
Mensink, R. P., Aro, A., Hond, E. D., German, J. B., Griffin, B. A., ten Meer, H.-U., Mutanen, M. L., Pannemans, D. L. E., & Stahl, W. (2003) · European Journal of Nutrition · doi:10.1007/s00394-003-1102-2 · Cited by 72
Soluble Adhesion Molecules and the Search for Biomarkers for Atherosclerosis
Ballantyne, C. M., & Entman, M. L. (2002) · Circulation · doi:10.1161/01.cir.0000028397.68936.12 · Cited by 71
The effects of conjugated linoleic acid supplementation on immune function in healthy volunteers
Nugent, A. P., Roche, H. M., Noone, E. J., Long, A., Kelleher, D. K., & Gibney, M. J. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602132 · Cited by 71
“Intercellular adhesion molecule-1 (ICAM-1, CD54), a transmembrane adhesion molecule expressed on endothelial cells, polymorphonuclear cells and fibroblasts (Kevil & Bullard, 1999). sICAM-1 is the product of proteolytic cleavage of the extracellular region of leukocyte ICAM-1 (Ghaisas et al, 1997) and levels are elevat…”
BackgroundAssociation Between Arsenic Exposure From Drinking Water and Plasma Levels of Cardiovascular Markers
Wu, F., Jasmine, F., Kibriya, M. G., Liu, M., Wójcik, O. P., Parvez, F., Rahaman, R. O., Roy, S., Paul-Brutus, R., Segers, S., et al. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr464 · Cited by 74
Oxysterol and Diabetes Activate STAT3 and Control Endothelial Expression of Profilin-1 via OSBP1
Romeo, G. R., & Kazlauskas, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710092200 · Cited by 74
Cazzola, R., Russo-Volpe, S., Miles, E. A., Rees, D., Banerjee, T., Roynette, C. E., Wells, S. J., Goua, M., Wahle, K. W. J., Calder, P. C., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.06.008 · Cited by 71
Valderas-Martínez, P., Chiva‐Blanch, G., Casas, R. M., Arranz, S., Martínez‐Huélamo, M., Urpí-Sardà, M., Torrado, X., Corella, D., Lamuela-Raventós, R. M., & Estruch, R. (2016) · Nutrients · doi:10.3390/nu8030170 · Cited by 75
“Soluble forms of endothelial adhesion molecules found in plasma are considered as an index of endothelial activation and even a biomarker of atherosclerosis [35].”
Hlubocká, Z., Umnerová, V., Heller, S., Peleska, J., Jindra, A., Jáchymová, M., Kvasnička, J., Horký, K., & Aschermann, M. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001403 · Cited by 71
Rosei, E. A., Rizzoni, D., Muiesan, M. L., Sleiman, I., Salvetti, M., Monteduro, C., & Porteri, E. (2005) · Journal of Hypertension · doi:10.1097/00004872-200502000-00027 · Cited by 71
Weight Reduction Decreases Soluble Cellular Adhesion Molecules In Obese Women
Ito, H., Ohshima, A., Inoue, M., Ohto, N., Nakasuga, K., Kaji, Y., Maruyama, T., & Nishioka, K. (2002) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2002.03672.x · Cited by 74
“In spite of these controversies, it is likely that soluble CAM are associated with atherosclerosis, which is supported by recent studies showing that the soluble CAM can be regarded as indices of the presence of atherosclerotic lesions and predict future cardiovascular events.(13) In conclusion, the present study has…”
BackgroundResultBiomarkers and HIV-associated cardiovascular disease
Baker, J. V., & Duprez, D. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed7ec · Cited by 76
Musso, G., Cassader, M., Bo, S., Michieli, F. D., & Gambino, R. (2012) · Diabetes · doi:10.2337/db12-0858 · Cited by 70
“atherosclerosis, and early cardiovascular risk (26).”
Katschke, K. J., Rottman, J. B., Ruth, J. H., Qin, S., Wu, L., LaRosa, G. J., Ponath, P. D., Park, C. C., Pope, R. M., & Koch, A. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5 · Cited by 287
Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques
Stefanadis, C. (2002) · European Heart Journal · doi:10.1016/s0195-668x(02)93174-x · Cited by 70
Osorio-Yáñez, C., Ayllón-Vergara, J. C., Aguilar‐Madrid, G., Mendoza, L. A., Hernández-Castellanos, E., Barrera-Hernández, Á., Vizcaya‐Ruíz, A. D., & Razo, L. M. D. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1205994 · Cited by 69
“Prospective cohort studies have reported that the plasma concentration of sICAM-1 is elevated many years before an initial myocardial infarction (Hwang et al. 1997; Ridker et al. 1998) but sICAM-1 has also been reported to be elevated in children with acute otitis media caused by bacterial infections (Liu et al.”
BackgroundRizzoni, D., Porteri, E., Guelfi, D., Muiesan, M. L., Piccoli, A., Valentini, U., Cimino, A., Girelli, A., Salvetti, M., Ciuceis, C. D., et al. (2001) · Journal of Hypertension · doi:10.1097/00004872-200105000-00012 · Cited by 69
Markers of Atherosclerosis: Part 1 – Serological Markers
Tibaut, M., Čaprnda, M., Kubatka, P., Sinkovič, A., Valentová, V., Filipová, S., Gazdíková, K., Gašpar, Ľ., Mozos, I. M., Egom, E. E. A., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.1057 · Cited by 74
High Sensitivity C-reactive Protein: An Emerging Role in Cardiovascular Risk Assessment
Benzaquen, L. R., Yu, H., & Rifai, N. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795556 · Cited by 68
Pasini, A. M. F., Garbin, U., Nava, M. C., Stranieri, C., Pellegrini, M., Boccioletti, V., LUCHETTA, M., Fabrizzi, P., LoCascio, V., & Cominacini, L. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.09.020 · Cited by 68
Tietge, U. J. F., Praticò, D., Ding, T., Funk, C. D., Hildebrand, R. B., van Berkel, T. J. C., & Eck, M. V. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400469-jlr200 · Cited by 68
Grundt, H., Nilsen, D. W. T., Mansoor, M. A., Hetland, Ø., & Nordøy, A. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000073852 · Cited by 68
Shai, I., Pischon, T., Hu, F. B., Ascherio, A., Rifai, N., & Rimm, E. B. (2006) · Obesity · doi:10.1038/oby.2006.245 · Cited by 68
Preston, R. A., Ledford, M. R., Materson, B. J., Baltodano, N. M., Memon, A., & Alonso, A. B. (2002) · Journal of Hypertension · doi:10.1097/00004872-200205000-00021 · Cited by 68
Pieringer, H., & Pichler, M. (2010) · QJM · doi:10.1093/qjmed/hcq203 · Cited by 69
Prasad, A., Koh, K. K., Schenke, W. H., Mincemoyer, R., Csákó, G., Fleischer, T. A., Brown, M., Selvaggi, T. A., & Quyyumi, A. A. (2001) · American Heart Journal · doi:10.1067/mhj.2001.116699 · Cited by 68
Emerging Noninvasive Biochemical Measures to Predict Cardiovascular Risk
Pahor, M., Elam, M. B., Garrison, R. J., Kritchevsky, S. B., & Applegate, W. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.3.237 · Cited by 67
“In the Physician’s Health Study, intercellular adhesion molecule 1 was significantly and independently associated with incident myocardial infarction.(112) DNA polymorphisms of adhesion molecule genes have been identified in young subjects with angiographically documented coronary atherosclerosis.”
BackgroundShort‐term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules
van Baal, Emeis, Kenemans, Kessel, Peters‐Muller, Schalkwijk, C. G., Mooren, V. D., & Stehouwer, C. D. A. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00565.x · Cited by 68
Quality of Sleep: Associations with Antiretroviral Nonadherence
Saberi, P., Neilands, T., & Johnson, M. O. (2011) · AIDS Patients Care and STDs · doi:10.1089/apc.2010.0375 · Cited by 60
Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?
Kraja, A. T., Province, M. A., Arnett, D. K., Wagenknecht, L. E., Tang, W., Hopkins, P. N., Djoussé, L., & Borecki, I. B. (2007) · Nutrition & Metabolism · doi:10.1186/1743-7075-4-28 · Cited by 68
Rodrigo Alonso, K., Mata, P., de Andrés, R., Villacastin, B. P., Martínez‐González, J., & Badimón, L. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00733-4 · Cited by 67
Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
Evans, J. R., & Lawrenson, J. G. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000253.pub3 · Cited by 71
Heliövaara, M. K., Teppo, A. M., Karonen, S. ‐., Tuominen, J. A., & Ebeling, P. R. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00463.x · Cited by 65
Donati, K. D. G., Ricardo Rabagliati, B., Tumbarello, M., Tacconelli, E., Amore, C., Cauda, R., & Iacoviello, L. (2003) · AIDS · doi:10.1097/00002030-200303280-00020 · Cited by 66
Roe, P., Wolfe, M., Joffe, M. M., & Rosas, S. E. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.016 · Cited by 66
Wang, C., Chen, R., Shi, M., Cai, J., Shi, J., Yang, C., Li, H., Lin, Z., Meng, X., Liu, C., et al. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx277 · Cited by 65
Effects of statins on inflammation in patients with acute and chronic coronary syndromes
Kinlay, S., & Selwyn, A. P. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03268-x · Cited by 66
Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?
Ridker, P. M. (2013) · Europe PMC (PubMed Central) · Cited by 67
Tatara, Y., Ohishi, M., Yamamoto, K. I., Shiota, A., Hayashi, N., Iwamoto, Y., Takeda, M., Takagi, T., Katsuya, T., Ogihara, T., et al. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.03.012 · Cited by 65
“risk factors and predictors of cerebro-cardiovascular disease; these include soluble P-selectin [4], soluble intracellular cell adhesion molecule-1 (sICAM-1) [5], soluble vascular cell adhesion molecule-1 (sVCAM-1) [6], interleukin-6 (IL-6) [7], tumor necrosis factor-α (TNF-α) [8], monocyte chemotactic protein-1 (MCP-…”
BackgroundProtection of Endothelial Function: Targets for Nutritional and Pharmacological Interventions
Sudano, I., Spieker, L. E., Hermann, F., Flammer, A. J., Corti, R., Noll, G., & scher, T. F. L. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200606001-00008 · Cited by 65
“Circulating levels of adhesion molecules correlate with cardiovascular mortality in patients with coronary artery disease.(65,66) The prevention of cytokine and adhesion molecule expression—in part mediated by NO—is an important antiatherosclerotic feature of HDL.”
BackgroundEffects of steroid hormones on vascular functions
Suzuki, T., Nakamura, Y., Moriya, T., & Sasano, H. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10246 · Cited by 64
“Therefore, determination of circulating adhesion molecule levels may be a useful marker of cardiovascular disease (Ridker et al., 1998).”
BackgroundChemokines in cardiovascular risk prediction
Yndestad, A., Smith, C., Ueland, T., Gullesta, L., Damås, J. K., & Aukrust, P. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0029 · Cited by 65
Hulthe, J., Wikstrand, J., Hultén, L. M., & Fagerberg, B. (2002) · Clinical Science · doi:10.1042/cs1030123 · Cited by 64
Hemelaar, M., van der Mooren, M. J., Rad, M., Kluft, C., & Kenemans, P. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.07.1298 · Cited by 64
HMG-CoA Reductase Inhibition: Anti-Inflammatory Effects beyond Lipid Lowering?
März, W., & Köenig, W. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000073686.78271.6d · Cited by 63
Hopelessness, Depression, and Early Markers of Endothelial Dysfunction in U.S. Adults
Phuong, D., Dowd, J. B., Ranjit, N., House, J. S., & Kaplan, G. A. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181e2cca5 · Cited by 63
Walter, M. F., Jacob, R. F., Bjork, R. E., Jeffers, B., Buch, J., Mizuno, Y., & Mason, R. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.051 · Cited by 63
Efficacy of voglibose in type 2 diabetes
Kaku, K. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.918956 · Cited by 63
“Levels of the inflammatory mediator sICAM-1 are directly associated with BMI, triglycerides and various inflammatory biomarkers [32] and, in a large epidemiological study, baseline sICAM-1 concentrations in the highest quartile were associated with an 80% higher risk of future myocardial infarction in otherwise appare…”
BackgroundEffect of Lowering of Homocysteine Levels on Inflammatory Markers
Durga, J., van Tits, L. J. H., Schouten, E. G., Kok, F. J., & Verhoef, P. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1388 · Cited by 63
“92 Oxidized LDL/LDL ratio, U/mmol 14 (10-19) 14 (10-19) .”
Weiss, C. R., Arai, A. E., Bui, M. N., Agyeman, K. O., Waclawiw, M. A., Balaban, R. S., & Cannon, R. O. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10023 · Cited by 63
“Twenty-two study participants had increases in wall thickness (14), T2-weighted signal intensity (11), and/or contrast enhancement values (7) that were >2 standard deviations (SDs) from control group mean values.”
Backgroundvan Haelst, P. L., van Doormaal, J. J., May, J. F., Gans, R. O. B., Crijns, H. J. G. M., & Tervaert, J. W. C. (2001) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(01)00172-8 · Cited by 63
Agarwal, S. (2009) · Angiology · doi:10.1177/0003319708330526 · Cited by 62
C-reactive protein: a 'golden marker' for inflammation and coronary artery disease.
PATEL, V. B., Robbins, M. A., & Topol, E. J. (2001) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.68.6.521 · Cited by 62
Angiotensin Receptor Blockade Decreases Markers of Vascular Inflammation
Graninger, M., Reiter, R. A., Drucker, C., Minar, E., & Jilma, B. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000137160.76616.cc · Cited by 62
Bielinski, S. J., Pankow, J. S., Li, N., Hsu, F., Adar, S. D., Jenny, N. S., Bowden, D. W., Wasserman, B. A., & Arnett, D. K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.031 · Cited by 62
“[5] Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J.”
BackgroundRidker, P. M., Chasman, D. I., Rose, L. M., Loscalzo, J., & Elias, J. A. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000897 · Cited by 61
Wöhrle, J., Nusser, T., Merkle, N., Kestler, H. A., Grebe, O. C., Marx, N., Höher, M., Kochs, M., & Hombach, V. (2006) · Journal of Cardiovascular Magnetic Resonance · doi:10.1080/10976640600737649 · Cited by 62
Alves, P., & Borba, E. F. (2008) · Swiss Medical Weekly · doi:10.4414/smw.2008.12287 · Cited by 62
Soluble e-selectin in essential hypertension: a correlate of vascular structural changes
Caterina, R. D. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01276-0 · Cited by 62
N-3 vs. saturated fatty acids: Effects on the arterial wall
Sudheendran, S., Chang, C.-T., & Deckelbaum, R. J. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.02.020 · Cited by 65
Neopterin: From Forgotten Biomarker to Leading Actor in Cardiovascular Pathophysiology
Rosa, S. D., Cirillo, P. L., Pacileo, M., Petrillo, G., D’Ascoli, G. L., Maresca, F., Ziviello, F., & Massimo Chiariello, A. (2011) · Current Vascular Pharmacology · doi:10.2174/157016111794519372 · Cited by 61
Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications
Montarello, N. J., Nguyen, M. T., Wong, D. T. L., Nicholls, S. J., & Psaltis, P. J. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07106-6 · Cited by 66
Why is soluble intercellular adhesion molecule‐1 related to cardiovascular mortality?
Becker‐Commissaris, A., van Hinsbergh, V. W. M., Jager, A., Kostense, P. J., Dekker, J. M., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00919.x · Cited by 61
Soluble adhesion molecules in healthy subjects: a dose-response study using n-3 fatty acids
Eschen, O., CHRISTENSEN, J., DeCaterina, R., & SCHMIDT, E. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80002-4 · Cited by 61
Non—Lipid-lowering effects of statins on atherosclerosis
Rosenson, R. S. (1999) · Current Cardiology Reports · doi:10.1007/s11886-999-0027-7 · Cited by 61
“Serum concentrations of ICAM-1, vascular cell adhesion molecule (VCAM-1), and E-selectin are elevated in patients with coronary and carotid atherosclerosis compared with control subjects [ 26 ,27].”
BackgroundTousoulis, D. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00250-8 · Cited by 60
Blum, A., Lang, N., Peleg, A., Vigder, F., Israeli, P., Gumanovsky, M., Lupovitz, S., Elgazi, A., & Ben‐Ami, M. (2003) · American Heart Journal · doi:10.1067/mhj.2003.115 · Cited by 60
“The pathophysiologic relevance of soluble cell adhesion molecules measured in human sera has been suggested by their localization in atherosclerotic plaques,(23,24) their higher levels in patients with atherosclerosis compared with control subjects,(25-27) and their association with increased risk of myocardial infarc…”
BackgroundStrączkowski, M., Lewczuk, P., Dzienis-Straczkowska, S., Kowalska, I., Stecedilpienacute, A., & Kinalska, I. (2002) · Metabolism · doi:10.1053/meta.2002.28095 · Cited by 60
Jiang, H., Klein, R. M., Niederacher, D., Du, M., Marx, R., Horlitz, M., Boerrigter, G., Lapp, H., Scheffold, T., Krakau, I., et al. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00138-9 · Cited by 59
Sena, C. M., Gonçalves, L. M. M., & Seiça, R. M. F. (2022) · The EPMA Journal · doi:10.1007/s13167-022-00280-7 · Cited by 60
Egert, S., Baxheinrich, A., Lee-Barkey, Y. H., Tschoepe, D., Wahrburg, U., & Stratmann, B. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514002001 · Cited by 58
“The levels of sICAM-1 predict future cardiovascular events in healthy subjects, and the reduction in the concentrations of these markers leads to a reduction in the risk of CVD(49).”
BackgroundInfluential
Metadata
- Authors
- Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- R&D Systems (United States) (US)
- Corresponding author
- Ridker, Paul M
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1998-01
- Volume
- 351
- Issue
- 9096
- Pages
- 88-92
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2138809584
- Cited by
- 1,229
- References
- 35
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 8 · 2023: 10 · 2022: 16 · 2021: 16 · 2020: 17 · 2019: 23 · 2018: 14 · 2017: 28 · 2016: 27 · 2015: 25 · 2014: 38 · 2013: 27 · 2012: 36
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- soluble intercellular adhesion molecule-1, sICAM-1, myocardial infarction, atherosclerosis, inflammation, endothelial cell adhesion, anti-adhesion therapy, cardiovascular risk, fibrinogen, homocysteine, tissue plasminogen activator, C-reactive protein, healthy men, Physicians' Health Study
- MeSH terms
- Antioxidants, Arteriosclerosis, Aspirin, Double-Blind Method, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Prospective Studies, Risk Factors, Multivariate Analysis, Case-Control Studies, Intercellular Adhesion Molecule-1, beta Carotene
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review